Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Polycystic Ovary Syndrome
100%
Non-Hispanic White
100%
Racial Differences
100%
Metabolic Phenotype
100%
Polycystic Ovarian Syndrome
63%
Hispanic
36%
Metabolic Syndrome
36%
Hispanic Women
36%
Cardiovascular Disease
18%
High Prevalence
18%
Insulin Resistance
18%
Hyperandrogenemia
18%
Metabolic Syndrome Prevalence
18%
Racial/ethnic Groups
18%
Secondary Data Analysis
9%
Body Mass Index
9%
High Mortality
9%
Academic Health Centers
9%
White Women
9%
Type 2 Diabetes Mellitus (T2DM)
9%
Low Prevalence
9%
Hyperandrogenism
9%
Severe Phenotype
9%
Waist Circumference
9%
Hypertriglyceridemia
9%
Hyperglycemia
9%
Prevention Strategies
9%
Serum Triglycerides
9%
Rotterdam Criteria
9%
Hirsutism
9%
High Morbidity
9%
Homeostasis Model Assessment
9%
Sex Hormone-binding Globulin
9%
Free Androgen Index
9%
Disease Understanding
9%
Controlled Clinical Trial
9%
Prospective multicenter
9%
Diabetes Mellitus
9%
Risk Factors for Development
9%
Low Serum
9%
Type II Diabetes Disease
9%
Metabolic Subtype
9%
Medicine and Dentistry
Polycystic Ovary Syndrome
100%
Race Difference
100%
Polycystic Ovarian Syndrome
100%
Ethnic Difference
100%
Metabolic Syndrome
85%
Prevalence
57%
Hyperandrogenism
42%
Cardiovascular Disease
28%
Maturity Onset Diabetes of the Young
28%
Insulin Resistance
28%
Secondary Data
14%
Diabetes Mellitus
14%
Body Mass Index
14%
Androgen
14%
Morbidity
14%
Ethnic Group
14%
Triacylglycerol
14%
Controlled Clinical Trial
14%
Hyperglycemia
14%
Homeostatic Model Assessment
14%
Hirsutism
14%
Sex Hormone Binding Globulin
14%
Hypertriglyceridemia
14%